Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Aug 30, 2021
Open Peer Review Period: Aug 30, 2021 - Sep 21, 2021
Date Accepted: Sep 17, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Values of Importance to Patients With Cardiovascular Disease as a Foundation for eHealth Design and Evaluation: Mixed Methods Study

Bente B, Wentzel M, Groeneveld R, IJzerman R, de Buisonjé D, Breeman L, Janssen V, Kraaijenhagen R, Pieterse M, van Gemert-Pijnen J, Evers A

Values of Importance to Patients With Cardiovascular Disease as a Foundation for eHealth Design and Evaluation: Mixed Methods Study

JMIR Cardio 2021;5(2):e33252

DOI: 10.2196/33252

PMID: 34677130

PMCID: 8571692

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Patient values: A foundation for eHealth design and evaluation in BENEFIT for all

  • B.E. Bente; 
  • M.J. Wentzel; 
  • R.G.H. Groeneveld; 
  • R.V.H. IJzerman; 
  • D.R. de Buisonjé; 
  • L.D. Breeman; 
  • V. Janssen; 
  • R. Kraaijenhagen; 
  • M.E. Pieterse; 
  • J.E.W.C. van Gemert-Pijnen; 
  • A. Evers

ABSTRACT

Background:

eHealth interventions are developed to support and facilitate patients with lifestyle changes and (self) care tasks after being diagnosed with a chronic heart disease. Creating long lasting effects in lifestyle change and health outcomes with eHealth interventions is challenging and requires good understanding of patient values.

Objective:

This study aims to identify which values of cardiac patients should be considered when designing a technological lifestyle platform.

Methods:

A mixed-method design was applied, combining data from usability testing with an additional online survey study, to validate the outcomes of the usability tests.

Results:

Eleven relevant patient values were identified, including the need for security, support, not wanting to feel anxious, tailoring of treatment, and personalized, accessible care. The validation survey shows that all values but one (Value 9: To have extrinsic motivation to accomplish goals or activities (related to health/lifestyle)) were regarded as important/very important. A rating of very unimportant or unimportant was given by less than 2% of the respondents (0.5%¬¬–1.6%) to all values except but one (Value 9).

Conclusions:

There is a remarkably high consensus among patients regarding the identified values reflecting goals and themes central to patients in their lives, while living with or managing their cardiovascular disease. The identified values can serve as a starting point for future research to translate and integrate these values into the design of the eHealth technology. This may call for prioritization of values, as not all values can be met equally.


 Citation

Please cite as:

Bente B, Wentzel M, Groeneveld R, IJzerman R, de Buisonjé D, Breeman L, Janssen V, Kraaijenhagen R, Pieterse M, van Gemert-Pijnen J, Evers A

Values of Importance to Patients With Cardiovascular Disease as a Foundation for eHealth Design and Evaluation: Mixed Methods Study

JMIR Cardio 2021;5(2):e33252

DOI: 10.2196/33252

PMID: 34677130

PMCID: 8571692

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.